AYTU AYTU BIOPHARMA, INC

$2.23 +6.19%

Healthcare · Pharmaceutical Preparations

AYTU BIOPHARMA, INC (AYTU) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $24 million. Shares last traded at $2.23, 25.7% below their 52-week high. Over the past year the stock is up 34.3%. Net profit margin is -20.4%, below the peer median of -0.1%. Revenue grew 1.8% year over year.

Market Cap

$24M

Shares Out

10.7M

EPS (TTM)

$-2.61

P/E Ratio

—

P/S Ratio

0.36

P/B Ratio

0.68

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.00

52-Week Low

$1.23

Volume

321

Avg Vol (3m)

884.508

Performance

+1.13%

+1.83%

-11.16%

+6.19%

YTD

-19.49%

+34.34%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

49.23

SMA (50)

$2.38

SMA (200)

$2.37

Price vs SMA50

-6.40%

Price vs SMA200

-5.73%

ATR (14)

$0.07

Financials

Revenue

$66M

Net Income

$-14M

Gross Margin

69.0%

Operating Margin

-11.8%

Net Margin

-20.4%

Return on Equity

-38.6%

Return on Assets

-12.1%

Current Ratio

1.12

Debt / Equity

0.27

Revenue Growth (YoY)

+1.8%

Latest reported annual period ending 2025-06-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2026	$-1.42	2026-05-13
Q2 2026	$-0.89	2026-02-03
Q1 2026	$-0.08	2025-11-13
Q3 2026	$-0.22	2026-05-13
Q2 2026	$-0.41	2026-02-03
Q1 2026	$-0.15	2025-11-13

Full earnings history →

Pharmaceutical Preparations peers

AYTU vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

0.36 / 3.54 med

-90% discount

Net margin vs peers

-20.4% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.